flumazenil has been researched along with Anti-Phospholipid Antibody Syndrome in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Manzano-Gamero, V | 1 |
Pardo-Cabello, AJ | 1 |
Vargas-Hitos, JA | 1 |
Zamora-Pasadas, M | 1 |
Navarrete-Navarrete, N | 1 |
Sabio, JM | 1 |
Jáimez-Gámiz, L | 1 |
Ríos-Fernandez, R | 1 |
Ortego-Centeno, N | 1 |
Ayala-Gutierrez, MM | 1 |
de Ramón, E | 1 |
Colodro-Ruíz, A | 1 |
Micó-Giner, L | 1 |
Castillo-Palma, MJ | 1 |
Robles-Marhuenda, Á | 1 |
Luna-Del Castillo, JD | 1 |
Jiménez-Alonso, J | 1 |
1 other study available for flumazenil and Anti-Phospholipid Antibody Syndrome
Article | Year |
---|---|
Effect of ethnicity on clinical presentation and risk of antiphospholipid syndrome in Roma and Caucasian patients with systemic lupus erythematosus: a multicenter cross-sectional study.
Topics: Abortion, Spontaneous; Adolescent; Adult; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; B | 2018 |